Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology March 2016 4(3):211-220 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587